A detailed history of Bank Of America Corp transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,367,915 shares of PMVP stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,367,915
Previous 1,439,841 5.0%
Holding current value
$2.49 Million
Previous $4.46 Million 47.9%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.51 - $3.12 $108,608 - $224,409
-71,926 Reduced 5.0%
1,367,915 $2.33 Million
Q4 2023

Feb 14, 2024

BUY
$1.23 - $6.6 $1.53 Million - $8.21 Million
1,243,924 Added 634.92%
1,439,841 $4.46 Million
Q2 2023

Aug 14, 2023

SELL
$3.94 - $6.27 $2.9 Million - $4.61 Million
-735,781 Reduced 78.97%
195,917 $1.23 Million
Q1 2023

May 12, 2023

SELL
$4.77 - $9.16 $398,380 - $765,024
-83,518 Reduced 8.23%
931,698 $4.44 Million
Q4 2022

Feb 10, 2023

BUY
$8.17 - $12.95 $4.42 Million - $7 Million
540,845 Added 114.01%
1,015,216 $8.83 Million
Q3 2022

Nov 14, 2022

BUY
$11.4 - $17.18 $483,873 - $729,205
42,445 Added 9.83%
474,371 $5.65 Million
Q2 2022

Aug 12, 2022

BUY
$9.23 - $22.43 $1.62 Million - $3.93 Million
175,089 Added 68.17%
431,926 $6.15 Million
Q1 2022

May 16, 2022

BUY
$14.86 - $23.55 $2.72 Million - $4.31 Million
183,018 Added 247.93%
256,837 $5.35 Million
Q4 2021

Feb 08, 2022

BUY
$19.99 - $30.24 $936,531 - $1.42 Million
46,850 Added 173.72%
73,819 $1.71 Million
Q3 2021

Nov 15, 2021

SELL
$26.84 - $36.58 $350,262 - $477,369
-13,050 Reduced 32.61%
26,969 $804,000
Q2 2021

Sep 13, 2021

BUY
$28.01 - $36.01 $1.12 Million - $1.44 Million
40,019 New
40,019 $1.37 Million

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $83M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.